首页> 外国专利> USE OF ACYLHYDRAZONES AND THE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF FOR PREVENTING THE DEVELOPMENT OF RESISTANCE OR REVERSING THE RESISTANCE OF TUMOURS TO CYTOSTATIC DRUGS

USE OF ACYLHYDRAZONES AND THE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF FOR PREVENTING THE DEVELOPMENT OF RESISTANCE OR REVERSING THE RESISTANCE OF TUMOURS TO CYTOSTATIC DRUGS

机译:使用乙二酮及其药学上可接受的盐来预防耐药性或逆转肿瘤对细胞抑制剂的耐药性

摘要

The invention relates to the use of acylhydrazones and the pharmaceutically acceptable salts thereof of the general formula I, where X, Y mean nitrogen or carbon respectively, wherein one residue X or Y is a nitrogen, and the other respective residue X or Y is a carbon; R1, R2 are a hydroxyl group or hydrogen respectively, wherein when a residue R1 or R2 is a hydroxyl group, the respective other residue R1, R2 is a hydrogen; R3 is a hydrogen or a methoxyl group and R4 is a methyl group or no further substituent, for preventing the development of resistance or reversing the resistance of tumours to cytostatic drugs.
机译:本发明涉及通式I的酰基hydr及其药学上可接受的盐的用途,其中X,Y分别表示氮或碳,其中一个残基X或Y为氮,而另一个各自的残基X或Y为氮。碳; R 1,R 2分别为羟基或氢,其中,当残基R 1或R 2为羟基时,其它的残基R 1,R 2为氢。 R 3是氢或甲氧基,R 4是甲基或没有其他取代基,以防止产生耐药性或逆转肿瘤对细胞生长抑制药的耐药性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号